Platelet dysfunction in diabetics has the potential to be discovered before any visible damage to the vessel wall manifests itself
GHK-Cu has not been approved for any therapeutic use in humans by the United States Food and Drug Administration (FDA), nor by any of its international regulatory counterparts
On the other hand, reducing the rate of drug excretion has the benefit of improving an individuals sensitivity to chemotherapeutic drugs, enhancing their curative effects
19.3+/-6.0 microg/L
DOES NOT CONTAIN:Sugar, Alcohol, Artificial Sweeteners, Artificial Colors, Preservatives, Gluten, Dairy, Soy, Tree Nuts, Peanuts, Eggs, Gelatin
Regular oral dosing provides sustained effects without medical supervision requirements